DIVIDEND ANNOUNCEMENT: Sh Ben Int/abrdn Life Sciences Investors (NYSE:HQL) on 02/10/2026 declared a dividend of $0.5600 per share

Sh Ben Int/abrdn Life Sciences Investors (NYSE:HQL) on 02/10/2026 declared a dividend of $ 0.5600 per share payable on March 31, 2026 to shareholders of record as of February 20, 2026. Dividend amount recorded is an increase of $ 0.06 from last dividend Paid.

Sh Ben Int/abrdn Life Sciences Investors (NYSE:HQL) has paid dividends since 1996, has a current dividend yield of 11.2817478180% and has increased its dividends for 1 successive years.

Sh Ben Int/abrdn Life Sciences Investors's market cap is $ 176,241,300 and has a PE ratio of 5.85. The stock price closed yesterday at $ 16.93 and has a 52 week low/high of $ 10.55 and $ 17.80.

Tekla Life Sciences Investors is a non-diversified closed-end management investment company. The Fund's investment objective is long-term capital appreciation through investment in United States and foreign companies in the life sciences industry (including biotechnology, pharmaceutical, diagnostics, managed healthcare and medical equipment, hospitals, healthcare information technology and services, devices and supplies), agriculture and environmental management. The Fund invests primarily in securities of public and private companies.

For more information on Sh Ben Int/abrdn Life Sciences Investors click here.